Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Neoplasms 2 Urinary Bladder Neoplasms 1 Prostatic Neoplasms 1 Pancreatic Neoplasms 1 PDAC - Pancreatic Ductal Adenocarcinoma 1 Neoplasms, Second Primary 1

Interventions

pembrolizumab 20 Gemcitabine 18 Cisplatin 14 enfortumab vedotin 12 Magnetic Resonance Spectroscopy 12 Specimen Handling 10 Cystectomy 10 Docetaxel 8 Mitomycin 7 Standard of Care 6 Cystoscopy 6 Transurethral Resection of Bladder 5 Radiotherapy 5 Carboplatin 5 durvalumab 4 Practice Guidelines as Topic 4 Nivolumab 4 Radiation 3 Multiparametric Magnetic Resonance Imaging 3 Mitozytrex 3 Fluorouracil 3 tislelizumab 2 dehydroftorafur 2 cemiplimab 2 avelumab 2 alvimopan 2 Therapeutics 2 Surveys and Questionnaires 2 Surgical Procedures, Operative 2 Radiosurgery 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Urinary Bladder Neoplasms × Registries × Clear all

NCT03413982 2026-03-10

GUB-BCR-001

University of Kansas Medical Center

Urinary Bladder Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡